Results 91 to 100 of about 208,684 (196)

Retinal Nerve Fiber Layer (RNFL) Thickness and Thyroid Orbitopathy

open access: yes, 2008
Since its introduction, OCT has become a great tool for evaluating optic neuropathies. To date, no study has investigated its use for thyroid orbitopathy and subsequent compressive optic neuropathy.
Eric Weber; Mehrak Marzban; Steven A. Newman
core  

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

open access: yes, 2016
Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though severe forms are rare. Management of GO is often suboptimal, largely because available treatments do not target pathogenic mech anisms of the disease.
Eckstein, A   +21 more
core   +1 more source

Papillary thyroid carcinoma with thyroid-associated orbitopathy in a euthyroid state

open access: yes, 2007
PURPOSE: Thyroid cancers with concurrent thyroid-associated orbitopathy (TAO) are extremely rare. The present study reports 5 unusual cases of papillary thyroid microcarcinoma in patients presenting with TAO in an euthyroid state.
남기현   +3 more
core   +1 more source

Thyroid-Associated Orbitopathy and Ocular Motility Disorders

open access: yes
Thyroid-associated orbitopathy is an autoimmune inflammatory disorder of the orbit associated with autoimmune thyroid disease. Autoimmune-mediated inflammation leads to the expansion of retrobulbar adipose tissue and extraocular muscles. This initiates a
Emma Grace Oreskovic   +4 more
core   +1 more source

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Overlap IgA Nephropathy: A Case Report

open access: yesCase Reports in Nephrology and Dialysis
Background: The anti-thyroid medication propylthiouracil (PTU) is a recognised cause of drug-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Georgina Oakman, Cindy Ong
doaj   +1 more source

Subconjunctival orbital fat prolapse and thyroid associated orbitopathy: a clinical association

open access: yes, 2017
Klio I Chatzistefanou,1 Christianna Samara,2 Ioannis Asproudis,3 Dimitrios Brouzas,1 Marilita M Moschos,1 Elisabeth Tsianta,1 George Piaditis4 1First Department of Ophthalmology, National and Kapodistrian University of Athens Medical School, Athens ...
Brouzas D   +6 more
core  

2018 European thyroid association guideline for the management of graves' hyperthyroidism

open access: yes, 2018
Graves' disease (GD) is a systemic autoimmune disorder characterized by the infiltration of thyroid antigen-specific T cells into thyroid-stimulating hormone receptor (TSH-R)-expressing tissues.
Leenhardt L   +13 more
core   +1 more source

The Role of Non-Surgical Management in Dysthyroid Orbitopathy

open access: yes, 1999
Dysthyroid orbitopathy (thyroid-associated orbitopathy or Graves\u27 ophthalmopathy) is the most common cause of both unilateral and bilateral proptosis in adults. This proptosis is usually accompanied by eyelid retraction, orbital congestion or motility
John S. Kennerdell, MD
core  

Teprotumumab - the new biological target in the management of thyroid orbitopathy [PDF]

open access: yes
Background. Thyroid orbitopathy (OT) represents a complex autoimmune condition with a varied ocular clinic such as diplopia, diminished vision and progressive alterations in facial appearance.
Cebotarean, Cristina, Paduca, Ala
core  

Home - About - Disclaimer - Privacy